Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9521 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.9518 |
High Similarity |
NPD6797 |
Phase 2 |
0.9461 |
High Similarity |
NPD7251 |
Discontinued |
0.929 |
High Similarity |
NPD7808 |
Phase 3 |
0.9226 |
High Similarity |
NPD7472 |
Approved |
0.9167 |
High Similarity |
NPD7054 |
Approved |
0.9107 |
High Similarity |
NPD3818 |
Discontinued |
0.9 |
High Similarity |
NPD7074 |
Phase 3 |
0.8988 |
High Similarity |
NPD6166 |
Phase 2 |
0.8988 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8988 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.897 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8947 |
High Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8909 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.883 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8735 |
High Similarity |
NPD3817 |
Phase 2 |
0.8623 |
High Similarity |
NPD5402 |
Approved |
0.8571 |
High Similarity |
NPD3882 |
Suspended |
0.8521 |
High Similarity |
NPD7075 |
Discontinued |
0.8503 |
High Similarity |
NPD1934 |
Approved |
0.8476 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8452 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8452 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8424 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8393 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8383 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8362 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8354 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8352 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8343 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8303 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8268 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8268 |
Intermediate Similarity |
NPD8312 |
Approved |
0.8242 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8239 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.8155 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8118 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8114 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.809 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8023 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8012 |
Intermediate Similarity |
NPD6190 |
Approved |
0.8011 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7988 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7978 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7976 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7966 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7956 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7953 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7946 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7939 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7933 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7921 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7919 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7917 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7898 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7897 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.788 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7879 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7879 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7874 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.787 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7853 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7853 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7816 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7784 |
Intermediate Similarity |
NPD3749 |
Approved |
0.776 |
Intermediate Similarity |
NPD6780 |
Approved |
0.776 |
Intermediate Similarity |
NPD6779 |
Approved |
0.776 |
Intermediate Similarity |
NPD6776 |
Approved |
0.776 |
Intermediate Similarity |
NPD6781 |
Approved |
0.776 |
Intermediate Similarity |
NPD6778 |
Approved |
0.776 |
Intermediate Similarity |
NPD6782 |
Approved |
0.776 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7758 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.774 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.774 |
Intermediate Similarity |
NPD919 |
Approved |
0.7738 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7711 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7696 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7677 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7677 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7665 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7657 |
Intermediate Similarity |
NPD37 |
Approved |
0.7633 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7627 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7627 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7627 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7627 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7602 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7602 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7602 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7576 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7569 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7568 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7556 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7551 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7551 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7551 |
Intermediate Similarity |
NPD7697 |
Approved |
0.755 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.755 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7515 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7515 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD943 |
Approved |
0.7515 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7513 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7513 |
Intermediate Similarity |
NPD8319 |
Approved |
0.75 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD6535 |
Approved |
0.75 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7487 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7471 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.747 |
Intermediate Similarity |
NPD1933 |
Approved |
0.746 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7437 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7427 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.741 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7391 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7385 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7385 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7376 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7368 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7365 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7356 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7337 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7337 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7323 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7321 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7294 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7289 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7289 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7288 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7288 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD920 |
Approved |
0.7257 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7257 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7257 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7257 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7243 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7234 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7228 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7212 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7191 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7178 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7172 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7156 |
Intermediate Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7128 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7126 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7092 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7092 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7092 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7091 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7069 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7066 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7052 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.705 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7035 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7035 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7012 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.6995 |
Remote Similarity |
NPD5353 |
Approved |
0.6979 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6978 |
Remote Similarity |
NPD6844 |
Discontinued |
0.6971 |
Remote Similarity |
NPD2800 |
Approved |
0.6971 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6964 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6961 |
Remote Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6959 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD2344 |
Approved |
0.6951 |
Remote Similarity |
NPD1091 |
Approved |
0.6939 |
Remote Similarity |
NPD4287 |
Approved |
0.6932 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6927 |
Remote Similarity |
NPD7039 |
Approved |
0.6927 |
Remote Similarity |
NPD7038 |
Approved |
0.6915 |
Remote Similarity |
NPD5242 |
Approved |
0.6905 |
Remote Similarity |
NPD9494 |
Approved |
0.6898 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6891 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6884 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.6884 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.6882 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6875 |
Remote Similarity |
NPD6674 |
Discontinued |
0.6872 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6862 |
Remote Similarity |
NPD5711 |
Approved |
0.6862 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6862 |
Remote Similarity |
NPD5710 |
Approved |
0.686 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.686 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6848 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6845 |
Remote Similarity |
NPD2798 |
Approved |
0.6839 |
Remote Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.6831 |
Remote Similarity |
NPD6385 |
Approved |
0.6831 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6831 |
Remote Similarity |
NPD6386 |
Approved |
0.6826
|
Remote Similarity |
NPD3225 |
Approved |